BIO builds on BIOEquality Efforts with New LinkdIn Group

Posted on Tue/17/AugustTue/17/August by AZBio

In 2020, BIO launched the BIOEquality Agenda, a national effort in collaboration with our partners in the biotechnology sector and BIO members that aims to counteract the systemic inequality, injustice, and unfair treatment of underserved communities.

Today, as part of the BIOEquality Agenda, Dr. Michelle McMurry-Heath, president & CEO of BIO, announced the launch of BIO’s new LinkedIn group, Forum for Diversity in Biotech and STEM to connect BIO members with diverse, talented, and industry-trained individuals. This group will be instrumental in helping our industry invest in the current and next generation of underrepresented scientists and make our entire sector stronger.
Continue reading→

Medical Device Development: Business Planning & Fundraising.

Posted on Fri/13/AugustFri/13/August by AZBio

On August 10^th2021, the International Society for Cardiovascular Translational Research (ISCTR), the Arizona Bioindustry Association (AZBio), and the University of Arizona James E. Rogers College of Law, Health Law & Policy Program partnered to present an educational webinar on Medical Device Development: Business Planning & Fundraising.Continue reading→

Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals

Posted on Thu/12/AugustThu/12/August by AZBio

Other fully vaccinated individuals do not need an additional vaccine dose right now.

Continue reading→

The NSF Awards ZelosDx $255,000 For the Development of WINDOW INTO THE BRAIN Biomarker Technology

Posted on Thu/12/AugustThu/12/August by AZBio

TUCSON, AZ, July 27, 2021 – ZelosDx, Inc. announced today that the company is the recipient of a Small Business Innovation Research (SBIR) Phase l Award from the National Science Foundation (NSF) for a grant entitled, “ Phagocytic Cells in Peripheral Blood as a Novel Diagnostic Tool for Brain Health”. The company will receive a one-year grant of up to $255,000 to expand the company’s pioneering biomarker research.Continue reading→

Wexford Innovation Labs Coming to Phoenix

Posted on Wed/11/AugustSat/14/August by AZBio

Wexford Science & Technology to Open Entrepreneurial Spaces in 850 PBC

Continue reading→

SEC approves Nasdaq’s Board Diversity Rule

Posted on Sun/8/AugustMon/9/August by AZBio

Nasdaq’s Board Diversity Rule, which was approved by the SEC on August 6, 2021, is a disclosure standard
designed to encourage a minimum board diversity objective for companies and provide stakeholders with
consistent, comparable disclosures concerning a company’s current board composition. A copy of the approval order can be viewed here.

Continue reading→

TGen leads international team to characterize blood-based clues of Parkinson’s Disease

Posted on Fri/6/AugustFri/6/August by AZBio

Immune system alterations could provide a path for future diagnostics and studies of this progressively debilitating neurological disease

Continue reading→

Humabiologics & Allegro 3D partner to provide human bioinks for rapid high throughput bioprinting and tissue models

Posted on Tue/3/AugustThu/5/August by AZBio

The convergence of the world’s first human bioinks and the most advanced digital light processing (DLP)-based bioprinter for direct printing in multiwell plates will accelerate high-throughput manufacturing of advanced human tissues for cell culture, drug screening, therapeutics and regenerative medicine. Continue reading→

Helios Scholars at TGen learn teamwork, technique and tenacity

Posted on Mon/2/AugustMon/2/August by AZBio

Aug. 3 symposium caps 8-week internship of real-life biomedical research sponsored by Helios Education FoundationContinue reading→

CyVerse Receives $1.3M to Provide Cyberinfrastructure and Training for New NSF Artificial Intelligence Institute

Posted on Thu/29/JulyFri/30/July by AZBio

CyVerse will provide computational infrastructure, data science and education to integrate the efforts of other partners of the NSF’s new AI Institute for Resilient Agriculture.

Continue reading→